Japanese researchers confirm efficacy of iPS cell-based cancer treatment

A group of researchers in Japan says it has confirmed a certain level of efficacy in using iPS cell-derived immune cells for ...

Startup: Tissue derived from iPS cells can treat heart failure

A Tokyo-based startup said transplants of cardiac muscle cells that it engineered from induced pluripotent stem (iPS) cells ...
Business Wire

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

TOKYO & MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and ...
Eagle-Tribune

Vita Therapeutics and I Peace announced a development program to generate iPS-derived differentiated cells for transplant therapy with an initial focus on FSHD ...

PALO ALTO, Calif., July 10, 2025 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. ( https://ipeace.com/en/), specializing in induced pluripotent stem cells (iPSCs ...
Morningstar

I Peace establishes and offers low immunoreaction risk GMP iPS Cells

Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response ...
Reuters

Japan approves test of iPS cells for treating spinal injuries

TOKYO (Reuters) - Japanese scientists will test the use of human-induced pluripotent stem cells (iPS) to treat spinal cord injuries, a health ministry panel that approved the research project said on ...